Pamela Ann Connealy - 24 Jun 2025 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Role
Director
Signature
/s/ Andrew Taylor, Attorney-in-Fact
Issuer symbol
OBIO
Transactions as of
24 Jun 2025
Net transactions value
$0
Form type
4
Filing time
26 Jun 2025, 17:17:03 UTC
Previous filing
02 Apr 2025
Next filing
08 Aug 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Connealy Pamela Ann Director C/O ORCHESTRA BIOMED HOLDINGS, INC., 150 UNION SQUARE DRIVE, NEW YORK /s/ Andrew Taylor, Attorney-in-Fact 26 Jun 2025 0001796310

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OBIO Common Stock, par value $0.0001 per share ("Common Stock") Award $0 +12,422 +58% $0.000000 33,711 24 Jun 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OBIO Stock Option (Right to Buy) Award $0 +36,797 $0.000000 36,797 24 Jun 2025 Common Stock 36,797 $3.22 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units ("RSUs") awarded to the Reporting Person on June 24, 2025 (the "Grant Date"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs will vest in one installment on the earlier of (x) the one year anniversary of the Grant Date or (y) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such dates.
F2 The stock options will vest in one installment on the earlier of (x) the one year anniversary of the Grant Date or (y) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such dates.